THE FORM FDA 1639 IS USED BY HEALTH
PROFESSIONALS AND DRUG MANUFACTURERS TO REPORT CASES OF SUSPECTED
ADVERSE DRUG REACTIONS. THE INFORMATION REQUESTED ON THE FORM IS
REVIEWED BY FDA TO IDENTIFY POTENTIAL SAFETY PROBLEMS WITH MARKETED
DRUG PRODUCTS AND FORMS THE BASIS FOR AGENCY RECOMMENDATIONS
REGARDING LABELING CHANGES OR OTHER REGULATORY ACTIONS.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.